1. Home
  2. PHAR vs RYI Comparison

PHAR vs RYI Comparison

Compare PHAR & RYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • RYI
  • Stock Information
  • Founded
  • PHAR 1988
  • RYI 1842
  • Country
  • PHAR Netherlands
  • RYI United States
  • Employees
  • PHAR N/A
  • RYI N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • RYI Metal Fabrications
  • Sector
  • PHAR Health Care
  • RYI Industrials
  • Exchange
  • PHAR Nasdaq
  • RYI Nasdaq
  • Market Cap
  • PHAR 618.3M
  • RYI 661.1M
  • IPO Year
  • PHAR N/A
  • RYI N/A
  • Fundamental
  • Price
  • PHAR $8.42
  • RYI $22.52
  • Analyst Decision
  • PHAR Strong Buy
  • RYI Hold
  • Analyst Count
  • PHAR 3
  • RYI 1
  • Target Price
  • PHAR $27.00
  • RYI $28.00
  • AVG Volume (30 Days)
  • PHAR 5.6K
  • RYI 279.1K
  • Earning Date
  • PHAR 03-13-2025
  • RYI 02-20-2025
  • Dividend Yield
  • PHAR N/A
  • RYI 3.42%
  • EPS Growth
  • PHAR N/A
  • RYI N/A
  • EPS
  • PHAR N/A
  • RYI 0.64
  • Revenue
  • PHAR $285,745,000.00
  • RYI $4,703,700,000.00
  • Revenue This Year
  • PHAR $20.08
  • RYI N/A
  • Revenue Next Year
  • PHAR $9.22
  • RYI $1.76
  • P/E Ratio
  • PHAR N/A
  • RYI $33.54
  • Revenue Growth
  • PHAR 30.64
  • RYI N/A
  • 52 Week Low
  • PHAR $6.65
  • RYI $17.18
  • 52 Week High
  • PHAR $13.20
  • RYI $36.15
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 40.05
  • RYI 58.61
  • Support Level
  • PHAR $7.95
  • RYI $20.99
  • Resistance Level
  • PHAR $9.35
  • RYI $23.50
  • Average True Range (ATR)
  • PHAR 0.52
  • RYI 0.83
  • MACD
  • PHAR -0.16
  • RYI 0.24
  • Stochastic Oscillator
  • PHAR 22.76
  • RYI 67.92

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority is from the United States.

Share on Social Networks: